General Healthcare News
A.I Versus M.D. – Part 2
In April I wrote a post entitled A.I. Versus M.D. – Either Way – Pathologists Do Not Diagnose Cancer – Part 1. This was followed by a guest post by David West, CEO, Proscia, entitled AI vs MD – What it Means for Pathology in May where...
Berci Mesko, MD, PhD, The Medical Futurist, a self-proclaimed "geek physician with a PhD in genomics and Amazon Top 100 author" who envisions "the impact of digital health technologies on the future of healthcare, and helps patients, doctors,...
It is now just six weeks until the Pathology Horizons 2017 conference in Cairns. Places are filling fast, so if you haven’t registered yet, make sure you sign up today. About the conference Pathology Horizons focuses on new...
Grail’s Billion Dollar Bet for the Perfect Cancer Test
- Advocacy
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Conferences
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- General Healthcare News
- Genetics
- Histology
- Laboratory Informatics
- Laboratory Management & Operations
- Liquid Biopsy
- Medical Research
- Molecular Pathology
- Pathology News
- Science
- Tissue banking
Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain...
VisionGate, Inc. recently announced the appointment of Dr. David Wilbur as Medical Director of its Phoenix-based CLIA laboratory, VisionGate Biosignatures Laboratory (VBL). A world-renowned pathologist, Dr. Wilbur comes to VisionGate from...
Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...
